Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 120

1.

Clinical Use of Professional Continuous Glucose Monitoring.

Wright EE Jr, Gavin JR 3rd.

Diabetes Technol Ther. 2017 May;19(S2):S12-S15. doi: 10.1089/dia.2017.0037. No abstract available.

2.

Response to Comment on Schwartz et al. The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell-Centric Classification Schema. Diabetes Care 2016;39:179-186.

Schwartz SS, Epstein S, Corkey BE, Grant SF, Gavin JR 3rd, Aguilar RB.

Diabetes Care. 2016 Aug;39(8):e129-30. doi: 10.2337/dci16-0011. No abstract available.

PMID:
27457644
3.

The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell-Centric Classification Schema.

Schwartz SS, Epstein S, Corkey BE, Grant SF, Gavin JR 3rd, Aguilar RB.

Diabetes Care. 2016 Feb;39(2):179-86. doi: 10.2337/dc15-1585.

4.

The efficacy and safety of canagliflozin across racial groups in patients with type 2 diabetes mellitus.

Gavin JR 3rd, Davies MJ, Davies M, Vijapurkar U, Alba M, Meininger G.

Curr Med Res Opin. 2015;31(9):1693-702. doi: 10.1185/03007995.2015.1067192. Epub 2015 Sep 4.

PMID:
26121561
5.

Safety and efficacy of colesevelam HCl in the treatment of elderly patients.

Gavin JR 3rd, Jones MR, Ford DM, Truitt KE.

Drugs Aging. 2014 Jun;31(6):461-70. doi: 10.1007/s40266-014-0174-4.

6.

Change in health status (EQ-5D) over 5 years among individuals with and without type 2 diabetes mellitus in the SHIELD longitudinal study.

Grandy S, Fox KM; SHIELD Study Group.

Health Qual Life Outcomes. 2012 Aug 21;10:99. doi: 10.1186/1477-7525-10-99.

7.

Rate and risk predictors for development of self-reported type-2 diabetes mellitus over a 5-year period: the SHIELD study.

Rodbard HW, Bays HE, Gavin JR 3rd, Green AJ, Bazata DD, Lewis SJ, Fox KM, Reed ML, Grandy S.

Int J Clin Pract. 2012 Jul;66(7):684-91. doi: 10.1111/j.1742-1241.2012.02952.x.

PMID:
22698420
8.

Self-reported hypoglycemia and impact on quality of life and depression among adults with type 2 diabetes mellitus.

Green AJ, Fox KM, Grandy S; SHIELD Study Group.

Diabetes Res Clin Pract. 2012 Jun;96(3):313-8. doi: 10.1016/j.diabres.2012.01.002. Epub 2012 Jan 31.

PMID:
22296853
9.

Common patient concerns about the use of glucagon-like peptide-1 receptor agonists in diabetes mellitus management.

Freeman JS, Gavin JR 3rd, Spellman CW.

J Am Osteopath Assoc. 2012 Jan;112(1 Suppl 1):S22-4.

PMID:
22267301
10.

Initiating a glucagon-like peptide-1 receptor agonist in the management of type 2 diabetes mellitus.

Gavin JR 3rd.

J Am Osteopath Assoc. 2012 Jan;112(1 Suppl 1):S16-21. Review.

PMID:
22267299
11.
12.

Type 2 diabetes mellitus: practical approaches for primary care physicians.

Gavin JR 3rd, Freeman JS, Shubrook JH Jr, Lavernia F.

J Am Osteopath Assoc. 2011 May;111(5 Suppl 4):S3-12; quiz S13. Review.

PMID:
21697547
13.

Treatment of heart failure in African Americans--a call to action.

Mitchell JE, Ferdinand KC, Watson KE, Wenger NK, Watkins LO, Flack JM, Gavin JR 3rd, Reed JW, Saunders E, Wright JT Jr.

J Natl Med Assoc. 2011 Feb;103(2):86-98.

PMID:
21443060
14.

Improving outcomes in patients with type 2 diabetes mellitus: practical solutions for clinical challenges.

Gavin JR 3rd, Stolar MW, Freeman JS, Spellman CW.

J Am Osteopath Assoc. 2010 May;110(5 Suppl 6):S2-14; quiz S15-6.

PMID:
20554501
15.

A new look at established therapies: practical tools for optimizing insulin use.

Gavin JR 3rd, Peragallo-Dittko V, Rodgers PT.

Diabetes Educ. 2010 May-Jun;36 Suppl 2:26S-38S; quiz 39S-40S. doi: 10.1177/0145721710369637.

PMID:
20511533
16.

A review of the response to oral antidiabetes agents in patients with type 2 diabetes.

Gavin JR 3rd, Bohannon NJ.

Postgrad Med. 2010 May;122(3):43-51. doi: 10.3810/pgm.2010.05.2141. Review.

PMID:
20463413
17.

Impact of type 2 diabetes mellitus on prescription medication burden and out-of-pocket healthcare expenses.

Rodbard HW, Green AJ, Fox KM, Grandy S; SHIELD Study Group.

Diabetes Res Clin Pract. 2010 Mar;87(3):360-5. doi: 10.1016/j.diabres.2009.11.021. Epub 2010 Jan 4.

PMID:
20047768
18.

Perceived body image in men and women with type 2 diabetes mellitus: correlation of body mass index with the figure rating scale.

Bays HE, Bazata DD, Fox KM, Grandy S, Gavin JR 3rd; SHIELD Study Group.

Nutr J. 2009 Dec 16;8:57. doi: 10.1186/1475-2891-8-57.

19.

Underutilisation of cardiovascular medications among at-risk individuals.

Lewis SJ, Robinson JG, Fox KM, Grandy S; SHIELD Study Group.

Int J Clin Pract. 2010 Apr;64(5):604-10. doi: 10.1111/j.1742-1241.2009.02258.x. Epub 2009 Nov 11.

20.

Atherosclerosis profile and incidence of cardiovascular events: a population-based survey.

Robinson JG, Fox KM, Bullano MF, Grandy S; SHIELD Study Group.

BMC Cardiovasc Disord. 2009 Sep 15;9:46. doi: 10.1186/1471-2261-9-46.

Supplemental Content

Loading ...
Support Center